Blue Ledge Capital
VC Fund
California City, United States
Blue Ledge Capital is a VC fund in California City focused on Health Care and Biotechnology. Blue Ledge Capital operates as a venture capital firm.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 75%
Last updated:
For AI agents: llms.txt
Industries Blue Ledge Capital invests in
Stages Blue Ledge Capital invests in
Countries Blue Ledge Capital invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Andy Roche
|
|||
Investment Focus
Industry
- Health Care 2 (50%)
- Biotechnology 2 (50%)
- AgTech 1 (25%)
- Medical 1 (25%)
- CleanTech 1 (25%)
Stage
- Seed 1 (25%)
- Series A 1 (25%)
- Series B 1 (25%)
- Venture - Series Unknown 1 (25%)
Country
- United States 2 (50%)
- United Kingdom 1 (25%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Andy Roche
Founder and CIO
|
Founder and CIO | Total investments: 4 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Qnovia
|
Respira Technologies is a platform device and biotechnology company focusing on aerosol science. The company is creating breakthrough aerosol devices and formulations that safely deliver a broad range of pharmaceuticals and nicotine.Respira Technologies' mission is to create novel medical devices of unparalleled efficiency and to advance theprotection of public health with consumer devices through novel innovation, responsible sourcing, draft legislative proposals, transparent product information, and common sense oversight. | $16M / Series B / Dec 10, 2024 | |
Entocycle
|
Entocycle is developing the world’s most efficient and sustainable way to produce protein. The rainforests and savannahs of South America are being destroyed at shocking rates in order to grow crops such as soy to feed farm animals. Using insects to feed livestock requires significantly less land and water compared to soy whilst being a naturalpart of the diet for many animals including fish, chickens and pigs. Their technology is significantly more efficient at producing protein than traditional methods of production as their insects are vertically farmed and not restricted to floor space or area. Thanks to their automated system they can produce at industrial scale and offer farmers a cost-effective and sustainable alternative to soymeal and fishmeal. | $2.6M / Venture - Series Unknown / Jul 18, 2024 | |
AvantGuard
|
AvantGuard creats innovative solutions that manage surfaces and provide long-term protection against viruses, bacteria, and fungi/mold, in a variety of applications. | $2.9M / Seed / May 11, 2023 | |
|
Qnovia
|
Respira Technologies is a platform device and biotechnology company focusing on aerosol science. The company is creating breakthrough aerosol devices and formulations that safely deliver a broad range of pharmaceuticals and nicotine.Respira Technologies' mission is to create novel medical devices of unparalleled efficiency and to advance theprotection of public health with consumer devices through novel innovation, responsible sourcing, draft legislative proposals, transparent product information, and common sense oversight. | $17M / Series A / Sep 28, 2022 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Blue Ledge Capital invest in?
Blue Ledge Capital invests primarily in Health Care, Biotechnology and AgTech startups, most often at Seed and Series A stage. Most of the 4 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Blue Ledge Capital?
Public channels for Blue Ledge Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Blue Ledge Capital?
The team at Blue Ledge Capital includes Andy Roche (Founder and CIO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
